start portlet menu bar

Web İçeriği Görüntüleyicisi

Display portlet menu
end portlet menu bar

Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Ana Sayfa Bilgi Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Vaccination with PRV vaccine (AUSKIPRA® GN; Bartha k61 strain), reduced virus shedding when challenge against Chinese PRV variant (AH02 strain)

Since 2011 several pseudorabies (PR) outbreaks have damaged Chinese swine industry. In this study MLV PRV vaccine (AUSKIPRA® GN reconstituted in A3 diluent, HIPRA) was challenged with new PRV variant (AH02 strain) isolated from a farm suffering from acute outbreak of PRV in China. Virus shedding on nasal swabs was studied in two independent experiments.

Bu makale hakkında

Yayınlanan

APVS Congress, 2015

Yazarlar

Zeng, R.; Wang, J.; Torrents, D.; Martinez, C.; Pedrazuela, R.

Özet

AUSKIPRA® GN vaccine reduce PRV shedding after AH02 strain challenge. Therefore, AUSKIPRA® GN can be a useful tool to control PRV infection in Chinese farms.

İlgili hizmetler

Paylaşın